Procter & Gamble Company (The) $PG Shares Sold by Prostatis Group LLC

Prostatis Group LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 12.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,304 shares of the company’s stock after selling 335 shares during the quarter. Prostatis Group LLC’s holdings in Procter & Gamble were worth $367,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Nova Wealth Management Inc. acquired a new stake in shares of Procter & Gamble in the 1st quarter worth $26,000. Signature Resources Capital Management LLC boosted its position in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares in the last quarter. Quarry LP acquired a new stake in shares of Procter & Gamble in the 1st quarter worth $33,000. Mizuho Securities Co. Ltd. boosted its position in shares of Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC purchased a new position in Procter & Gamble in the 2nd quarter worth $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG opened at $149.69 on Monday. The stock has a 50-day simple moving average of $155.24 and a two-hundred day simple moving average of $159.41. The firm has a market capitalization of $350.34 billion, a P/E ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a fifty-two week low of $149.45 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm earned $1.40 EPS. The company’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Insider Activity

In other news, CEO Jon R. Moeller sold 11,684 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the sale, the chief executive officer directly owned 319,932 shares in the company, valued at $48,703,248.36. This trade represents a 3.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Andre Schulten sold 4,252 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $647,281.96. Following the sale, the chief financial officer owned 53,992 shares in the company, valued at $8,219,202.16. This trade represents a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on PG. Evercore ISI restated an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. BNP Paribas restated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. UBS Group reduced their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research note on Wednesday. Bank of America reduced their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research note on Friday. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $172.21.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.